Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors

Qian Dong(Chinese Academy of Sciences), Wei Huang(Chinese Academy of Sciences), Mengya Tong(Chinese Academy of Sciences), Likun Gong(Nanjing University of Chinese Medicine), Shanhua Fang(Chinese Academy of Sciences), Xiaolu Yu(Chinese Academy of Sciences), Yongliang Tong(Shanghai Medical College of Fudan University), Liguang Lou(Shanghai Institute of Materia Medica), Hu Zhou(University of Science and Technology of China), Jiwei Ao(Chinese Academy of Sciences), Lei Wang(Tongji University), Junjie Liu(Chinese Academy of Sciences), Yubo Tang(Sun Yat-sen University), Yongzhuo Huang(Nanjing University of Chinese Medicine), Long Li(Chinese Academy of Sciences), Dongliang Guan(Chinese Academy of Sciences)
Journal of Medicinal Chemistry
May 25, 2023
10.1021/acs.jmedchem.2c01347
Cited by 9

Related Papers

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
|Cell|2019|1.2k
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity <i>in vitro</i> and <i>in vivo</i>
|Cancer Science|2011|519
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor
|Cancer Science|2018|368
Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy
|Chemical Science|2018|248
Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery
|Theranostics|2018|212